Coronation Street actor Will Mellor took to social media to share his "hidden talent" as returning soap star Ryan Thomas ...

SeeMe's beauty Inclusivity Index for 2025 found that brands labeled as Certified Inclusive outpaced the growth of less ...

Mallinckrodt and Endo, drugmakers with a shared history of bankruptcy and U.S. opioid litigation, will merge in a deal valued ...

Makeup company L’Oréal has recalled popular brand La Roche-Posay’s acne cream because it may contain benzene, a ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Ozempic and other similar drugs must be injected. Messer describes the needle as “small, the size of two human hairs.” ...

The Indigenous People of Biafra (IPOB) has accused officials of the National Agency for Food and Drug Administration and Control (NAFDAC) of looting goods at Onitsha drug market, popularly known as ...

Endo shareholders will get $80 million in cash and own 49.9 per cent of the combined company, while Mallinckrodt shareholders ...

Toronto-based healthtech startup Phoenix has closed $50 million CAD in equity and debt to help men suffering from erectile ...

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...

Homegrown pharmaceutical companies launching significantly cheaper generic versions of empagliflozin—a widely prescribed SGLT2 inhibitor for type-2 diabetes ...